在奥地利使用药物检查服务:一个跨部门在线调查
Alexandra Karden1,2, Tobias Fragner3, Cornelia Feichtinger2,4
1Suchthilfe Wien gGmbH (Vienna Addiction Services), Gumpendorfer Gürtel 8, Vienna, 1060, Austria.
Harm reduction journal
|February 15, 2025
概括
在奥地利,药物检查服务是值得信赖的,但并非同样容易获得的. 扩大可用性可以接触到更多使用毒品的人,特别是大麻使用者和农村地区的人.
科学领域:
- 公共卫生 公共卫生
- 预防成 预防成
- 减少伤害 减少伤害
背景情况:
- 精神活性物质的使用给公共卫生带来了重大挑战.
- 在奥地利建立了毒品检查服务,减少危害和预防成的措施.
- 这项研究调查了在奥地利使用毒品的人群 (PWUD) 中的药物检查使用率和用户特征.
研究的目的:
- 为了确定在奥地利的PWUD中使用药物检查服务的普及率.
- 确定社会人口和物质使用特征,区分药物检查用户与非用户.
- 探索无法利用可用的药物检查服务的原因.
主要方法:
- 欧洲网络毒品调查 (EWSD) 奥地利数据 (2021年3月至5月) 的二次数据分析.
- 具有和没有先前药物检查经验的PWUD的比较.
- 单变量和多变量分析以确定显著差异和预测因素.
主要成果:
- 样本中20.1%的PWUD报告使用药物检查服务.
- 在使用者和非使用者之间,在年龄,教育,就业,地区,物质使用和治疗史方面发现了显著的差异.
- 仅使用大麻的个人,以及那些在农村地区或与父母住在一起的人,对药物检查的经验较少. 对供应源和物质质量的高度信任是不使用的主要原因.
结论:
- 在奥地利,药品检查服务普遍被接受和信任.
- 在PWUD中,可访问性和利用率分布不均.
- 需要扩大服务的可用性和可访问性,以达到服务不足的人群,包括仅使用大麻的用户和农村环境中的用户.
更多相关视频
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Pharmacovigilance
768
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
768
Prescription, Nonprescription and Orphan Drugs
681
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
681
Drug Concentrations: Measurements
307
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
307
Analysis of Population Pharmacokinetic Data
216
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
216
Drug Control Governance: Regulatory Bodies and Their Impact
136
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
136


